683 related articles for article (PubMed ID: 2904218)
1. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
2. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of pirenzepine and ranitidine on the nocturnal intragastric pH in non-responders to ranitidine.
Walker S; Klotz U; Bode JC
Z Gastroenterol; 1990 Aug; 28(8):379-82. PubMed ID: 2275257
[TBL] [Abstract][Full Text] [Related]
5. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
de Gara CJ; Burget DW; Silletti C; Hunt RH
Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
[TBL] [Abstract][Full Text] [Related]
6. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
7. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
Bianco A; Cagossi M; Piraccini R; Greco AV
Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
[TBL] [Abstract][Full Text] [Related]
11. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
12. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
Thomson AB
Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
[TBL] [Abstract][Full Text] [Related]
13. Daily gastric pH in controls and in duodenal ulcer patients: basal condition and response to treatment.
Masoero G; Rossanino A; Arossa W; Marchetto M; Marucci M; De la Pierre M
Am J Gastroenterol; 1988 Feb; 83(2):136-42. PubMed ID: 3341336
[TBL] [Abstract][Full Text] [Related]
14. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
[TBL] [Abstract][Full Text] [Related]
15. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
[TBL] [Abstract][Full Text] [Related]
16. Antacids and anticholinergics in the treatment of duodenal ulcer.
Walan A
Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
[TBL] [Abstract][Full Text] [Related]
17. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
[TBL] [Abstract][Full Text] [Related]
18. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
Lezoche E; Vagni V; D'Alessandro MD; Mariani P; Carlei F; Lomanto D; Nardovino M; Martelli A; Speranza V
Drugs Exp Clin Res; 1987; 13(10):655-8. PubMed ID: 2892658
[TBL] [Abstract][Full Text] [Related]
19. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
20. Low doses of H2 antagonists and interaction with anticholinergics.
Savarino V; Mela GS; Celle G
Am J Gastroenterol; 1989 Nov; 84(11):1463-4. PubMed ID: 2816882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
